StockWatch
·
Pharmaceuticals
Quarterly Result22 May 2026, 06:41 pm

Syncom Formulations: FY26 Revenue ₹486.57 Mn

AI Summary

Syncom Formulations India Ltd. has released its standalone and consolidated audited financial results for the year ended March 31, 2026. Key figures include revenue from operations of ₹486.57 million and a profit of ₹76.01 million for the period. The board meeting approving these results took place on May 22, 2026. Auditors' report is unmodified, requiring no further comments from the company. The results will be published in English and Marathi newspapers and filed in XBRL format.

Key Highlights

  • Revenue from operations for FY26 stood at ₹486.57 million.
  • Profit for the period from continuing operations is ₹76.01 million.
  • Auditors' report on the financial results is unmodified.
  • Board approved the results in a meeting held on May 22, 2026.
  • The company will file the results in XBRL format and publish them in newspapers.